跳至主要内容
临床试验/TCTR20150409001
TCTR20150409001招募中1 期

The safety and result of intratumoral steroid injection for aggressive fibromatosis

Faculty of medicine, Chiang mai University0 个研究点目标入组 10 人开始时间: 2015年4月9日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.Patients who have been diagnosed AF by MSK-Oncology Board (MSK-OB) of Chiang Mai University and give consent to participate in this research, and
  • 2.The disease has recurred at least one episode and progressed after the wide resection had been performed, and
  • -Patients have experience of constant pain and not response to conservative treatment, or
  • -The primary lesion shows locally aggressive by involving large area of normal tissue (comparing to previous MRI), and the operation is expected to create unacceptable morbidity.

排除标准

  • 1.Patients who have bleeding tendency
  • 2.Patients who depended on systemic steroid use by other conditions
  • 3.Patients who have contra-indication for steroid use including poor control diabetes, active infection, pregnancy and lactation.

研究者

发起方
Faculty of medicine, Chiang mai University

相似试验